Specificity of the control of tumor formation by the blastocyst.
An assay to determine the mechanism of regulation of embryonal carcinoma cells by the blastocyst, which is based on a comparison of tumors produced when the cancer cells are cloned alone or after incorporation into blastocysts, was refined by labeling embryonal carcinoma cells with fluorescent microspheres and by following their fate after injection into the blastocysts. Through the use of the new techniques, it was observed that cells of one line of nullipotent embryonal carcinoma were controlled at the 50% level, those from another were not controlled, and those from a multipotent but undifferentiated line were controlled in almost absolute fashion. Single Sarcoma 180 of L1210 leukemia cells were not controlled when injected into the blastocele, but C1300 neuroblastoma cells were partially controlled. None of these tumors have a normal cellular counterpart in the blastocyst, as does embryonal carcinoma, but neurulation follows blastulation by only a few days, so that the neuroblastoma cells may be regulated at that time. Parietal yolk sac carcinoma cells, which have a counterpart in the late blastocyst, were not controlled. On the basis of these data, it is postulated that, if one embryonic field can regulate its closely related cancer, then there may be an embryonic field capable of regulating each carcinoma.
D000818:Animals; D001755:Blastocyst; D002460:Cell Line; D003584:Cytological Techniques; D004624:Embryo Transfer; D007939:Leukemia L1210 / Q000473:pathology; D008649:Mesonephroma / Q000473:pathology; D051379:Mice; D009368:Neoplasm Transplantation; D009373:Neoplasms, Germ Cell and Embryonal / Q000473:pathology*; D009447:Neuroblastoma / Q000473:pathology; D011336:Probability; D012510:Sarcoma 180 / Q000473:pathology